InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: jaime9_2000 post# 43489

Wednesday, 06/01/2022 11:02:10 PM

Wednesday, June 01, 2022 11:02:10 PM

Post# of 44784
There’s always new people to milk. Who knows the UAE could bring some new cash. They haven’t done a raise for some time since the Covid cash cow. But need to keep that war chest as fat as possible. Doing nothing costs a fortune.

Throw HCT into a phase 2. That’s good for a few years of milk. Pluristem and Tnuva could just keep silent for a few years too. Like UTHR or CHA deals. Won’t even mention the Japanese partner they should have by the end of 2016 as promised. Bring back some GvHD pre-clinical results and start a phase 1. Throw away some more cash and hire another SSCIENTIFIC steering committee on preeclampsia. Who cares if you have to pay them. Some will lap it up like good little minions.

But seriously I could see them getting to half a billion. Only another $150 mil to go. How they’ve made it to $350 mil so far is mind blowing. But raises are the ONLY thing this company does well. All to benefit employees ONLY unfortunately.